Prescription medicine
Dextran 40 Brand names: Lmd
Dextran 40 (Lmd) is a prescription medicine. FDA's NDC Directory lists it from 1 generic labeler.
- Generic listed
Check it at the source: the dextran 40 FDA label on DailyMed (effective May 22, 2026); every dextran 40 label on DailyMed.
Highlights of the record
FDA label of May 22, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageLMD (dextran 40) is indicated for use in the adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma.
Forms and strengths
- 10 g/100ml
Injection (solution).
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 1 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 1 since 2019 0 Class I among all firms' recalls; latest October 2, 2019
- FAERS reports
- 72 through July 30, 2026
What is dextran 40 used for?
From the label: indications and usageLMD (dextran 40) is indicated for use in the adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma. It is not indicated as a replacement for whole blood or blood components if they are available. It should not replace other forms of therapy known to be of value in the treatment of shock. LMD is also indicated for use as a priming fluid, either as a sole prime or as an additive, in pump oxygenators during extracorporeal circulation. […]
Conditions named in the indications of dextran 40's FDA labels, with every medicine labeled for each:
From other dextran 40 labelsBlood clots (DVT and PE): LMD is also indicated for use in prophylaxis of venous thrombosis and pulmonary embolism in patients undergoing procedures known to be associated with a high incidence of thromboembolic complications, such as hip surgery.
FDA pharmacologic class: Plasma Volume Expander.
Source: FDA drug label (LMD in Dextrose), Hospira, Inc., effective May 22, 2026 (SPL set 3c273512-84e2-2cea-b201-12345a6bd1fe), via openFDA; the full label on DailyMed
Is there a generic for dextran 40 (Lmd)?
No generic dextran 40 is approved (Drugs@FDA, October 8, 2026).
FDA's NDC Directory lists dextran 40 from 1 labeler under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Has dextran 40 been recalled?
The FDA's Enforcement Report lists 1 recall naming dextran 40 since 2019: 0 Class I (the most serious), 1 Class II, 0 Class III; 0 still ongoing. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| October 2, 2019 | Class II | Pfizer Inc. | Lack of Assurance of Sterility: Bag has the potential to leak. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the dextran 40 label say about other medicines?
The dextran 40 label names 2 other medicines in its interaction, contraindication or warning sections. The labels of 1 other medicine name dextran 40. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Heparin | contraindications | CONTRAINDICATIONS LMD (dextran 40) is contraindicated in patients with known hypersensitivity to dextran, in those with marked hemostatic defects of all types (thrombocytopenia, hypofibrinogenemia, etc.) including those caused by drugs (heparin, warfarin, etc.), marked cardiac decompensation and in renal disease with … |
| Warfarin | contraindications | CONTRAINDICATIONS LMD (dextran 40) is contraindicated in patients with known hypersensitivity to dextran, in those with marked hemostatic defects of all types (thrombocytopenia, hypofibrinogenemia, etc.) including those caused by drugs (heparin, warfarin, etc.), marked cardiac decompensation and in renal disease with … |
Other labels that name dextran 40
Source: FDA drug label (LMD in Dextrose), Hospira, Inc., effective May 22, 2026 (SPL set 3c273512-84e2-2cea-b201-12345a6bd1fe), via openFDA; the full label on DailyMed
What do FAERS reports show for dextran 40?
The FDA Adverse Event Reporting System holds 72 reports that list dextran 40 among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 9 are coded as a death and 26 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What else is labeled for the same conditions as dextran 40?
1 other medicine is given the same way (intravenous) and in the same FDA class as dextran 40 or labeled mainly for the same use (blood clots (DVT and PE)), the same class first. Blood clots (DVT and PE) lists all 12 medicines labeled for it, by any route. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (intravenous) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Heparin | Blood clots (DVT and PE) | 18 labelers | $1.18 per mL 5,000 unit/mL vial | In shortage |
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
What next?
- Other plasma volume expanders
- the pharmacologic class, with prices and generics
- Dextran 40 side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other